Cytokinetics challenges BMS patent in bid to clear MYQORZO launch obstacle
Published Cytokinetics has launched a Delaware patent action against Bristol Myers Squibb and its MyoKardia subsidiary, seeking to clear a recently issued patent that it says does not cover its cardiac myosin inhibitor MYQORZO (aficamten). Cytokinetics filed the...
Winter IP Conference 2026: 5 November, London UK
Published After two highly successful and well-regarded annual events, we’re thrilled to announce the Winter Intellectual Property Conference 2026, now with a brand-new format designed to deliver even more value. This single-day event brings the entire IP community...
ByteDance (TikTok) joins the Open Invention Network 2.0 community
Published Open source software is the engine for almost every enterprise stack. Open Invention Network (OIN) was created to safeguard open source from bad actors. Over the last two decades, open source has been able to flourish, driving innovation in the software...
